药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
Gemfibrozil
The metabolism of Indacaterol can be decreased when combined with Gemfibrozil.
Trilostane
Metreleptin
The metabolism of Indacaterol can be increased when combined with Metreleptin.
Trilostane
Relugolix
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Relugolix.
Trilostane
Fostemsavir
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fostemsavir.
Trilostane
Gallopamil
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gallopamil.
Trilostane
Rilpivirine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Rilpivirine.
Trilostane
Lidoflazine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lidoflazine.
Trilostane
Bencyclane
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Bencyclane.
Trilostane
Triclabendazole
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Triclabendazole.
Trilostane
Delafloxacin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Delafloxacin.
Trilostane
Ebastine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ebastine.
Trilostane
Rupatadine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Rupatadine.
Trilostane
Aranidipine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Aranidipine.
Trilostane
Pinaverium
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pinaverium.
Trilostane
Trimebutine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Trimebutine.
Trilostane
Lurasidone
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lurasidone.
Trilostane
Levocetirizine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Levocetirizine.
Trilostane
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Indacaterol.
Trilostane
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Indacaterol.
Trilostane
Orphenadrine
The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Indacaterol.